In the last few months, the European Court of Justice (ECJ) has handed down several decisions relating to the grant and validity of supplementary protection certificates (SPCs; i.e. patent term extensions). Thereof, the following rulings are generally considered to have significant impact on IP strategies in the pharmaceutical industry.
Recevie Email Updates
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.